These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 11070088)

  • 1. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.
    Li YY; Feng YQ; Kadokami T; McTiernan CF; Draviam R; Watkins SC; Feldman AM
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12746-51. PubMed ID: 11070088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure.
    Li YY; Kadokami T; Wang P; McTiernan CF; Feldman AM
    Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H983-9. PubMed ID: 11834496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
    Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
    Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A.
    Vellaichamy E; Khurana ML; Fink J; Pandey KN
    J Biol Chem; 2005 May; 280(19):19230-42. PubMed ID: 15710627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.
    Wang JH; Su F; Wang S; Lu XC; Zhang SH; Chen D; Chen NN; Zhong JQ
    Int J Clin Exp Pathol; 2014; 7(10):6514-23. PubMed ID: 25400729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
    Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
    Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling].
    Wang XM; Yang LX; Zhu SJ; Yang YJ; Guo CM; Qi F; Wei L; Shi YK; Wang Y; Ren L
    Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):828-31. PubMed ID: 15634542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].
    Wei M; Gu SM; Zhang YY; Wu YH; Wu ZG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):444-7. PubMed ID: 15932706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].
    Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP
    Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble TNF receptors prevent apoptosis in infiltrating cells and promote ventricular rupture and remodeling after myocardial infarction.
    Monden Y; Kubota T; Tsutsumi T; Inoue T; Kawano S; Kawamura N; Ide T; Egashira K; Tsutsui H; Sunagawa K
    Cardiovasc Res; 2007 Mar; 73(4):794-805. PubMed ID: 17266945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor.
    Sivasubramanian N; Coker ML; Kurrelmeyer KM; MacLellan WR; DeMayo FJ; Spinale FG; Mann DL
    Circulation; 2001 Aug; 104(7):826-31. PubMed ID: 11502710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myocardial matrix metalloproteinases activities in mice with viral myocarditis and their relationship with cardiac function and myocardial collagen amount].
    Meng XH; Wang Y; Zhuang JX; Chen Y; Jin YP; Han XZ; Wang YL
    Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):605-8. PubMed ID: 15347449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.
    Foronjy RF; Sun J; Lemaitre V; D'Armiento JM
    Hypertens Res; 2008 Apr; 31(4):725-35. PubMed ID: 18633185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices.
    Li YY; Feng Y; McTiernan CF; Pei W; Moravec CS; Wang P; Rosenblum W; Kormos RL; Feldman AM
    Circulation; 2001 Sep; 104(10):1147-52. PubMed ID: 11535571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling.
    Gurantz D; Yndestad A; Halvorsen B; Lunde OV; Omens JH; Ueland T; Aukrust P; Moore CD; Kjekshus J; Greenberg BH
    Cardiovasc Res; 2005 Jul; 67(1):106-15. PubMed ID: 15949474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy.
    Kawamura N; Kubota T; Kawano S; Monden Y; Feldman AM; Tsutsui H; Takeshita A; Sunagawa K
    Cardiovasc Res; 2005 Jun; 66(3):520-9. PubMed ID: 15914117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction.
    Sun M; Dawood F; Wen WH; Chen M; Dixon I; Kirshenbaum LA; Liu PP
    Circulation; 2004 Nov; 110(20):3221-8. PubMed ID: 15533863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
    Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
    J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.